• Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Prevas: Organic recovery delayed further - ABG

PREV BThird party research20.07.2026 klo 08.16

This is a third party research report and does not necessarily reflect our views or values

Download report (PDF)
* Organic decline of 2%, weighed down by Finland
* Adj. EBITA margin of 5.6%, below the 6.9% expected
* Trading at 6x adj. EV/EBITA on '27e

Changes in Finland will likely take time
The report came in softer than expected, with an organic decline of 2% continuing to weigh on growth. Most important here is adj. EBITA, which came in SEK 5m below our estimate, at a margin of 5.6% (vs. 6.9% expected). This was mainly due to weaker demand in Finland, driven by a customer that has made major layoffs, directly affecting Prevas. Postponed deliveries also weighed on the quarter, though we expect these to materialise as early as Q3. To address demand in Finland, the company took SEK 8m of restructuring costs, which we view as necessary to build a stronger foundation and improve margins.

Organic growth taking longer to turn around
We therefore lower our '26 sales estimate by 2% and adj. EBITA by 14%. Worth noting for consulting firms, organic growth is driven primarily by three things. 1) The calendar effect, i.e. working days compared to last year, 2) price increases and utilisation, and 3) whether FTEs are growing or decreasing. On price and utilisation, the company is able to raise prices despite competition and improve utilisation. FTEs are where it gets tough, as consulting firms have to lay off personnel to align with lower demand, which directly cuts organic growth through fewer billable hours. So what matters most here is the adj. EBITA margin, which we expect to gradually improve as changes take effect.

Increasing margins in focus
A return to positive organic growth will take longer than anticipated. Focus remains on restructuring to lift margins, with benefits expected to become more visible through H2. At current levels, Prevas is trading at 6x adj. EV/EBITA on '27e, well below its historical median and around 30% below peers.